united therapeutics glp-1 receptor agonist Frontiers The Unstoppable Rise of GLP-1
Description
S.ChenY.FazioliK.RivaraM
For patients with severe obesity and metabolic disease, this is a giftlife-extending, even lifesaving
Application of statistical and/or mathematical analyses: A.R.S., J.B.K., D.R.D., C.B., and J.-P.F
ESC The ESC guidelines recommend the use of GLP-1 RAs in overweight or obese patients with T2DM to promote weight reduction (Class IIa, LoE B)
Burgmaier M, Liberman A, Mollmann J, Kahles F, Reith S, Lebherz C, et al
